SMTL ID : 4cfw.2 (1 other biounit)

Structure-based design of C8-substituted O6-cyclohexylmethoxyguanine CDK1 and 2 inhibitors.

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.45 Å

Oligo State

hetero-oligomer

Ligands

1 x SQ9: 3-[2-AMINO-6-(CYCLOHEXYLMETHOXY)-7H-PURIN-8-YL]-2-METHYLBENZENESULFONAMIDE(Non-covalent)

SQ9.1: 16 residues within 4Å: Chain A: I.15, Y.20, A.36, V.69, F.85, E.86, F.87, L.88, H.89, Q.90, D.91, K.94, Q.136, N.137, L.139, D.150 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:I.15, A:F.87, A:D.150 Hydrogen bonds: A:L.88, A:L.88, A:D.91, A:D.91, A:K.94

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Carbain, B. et al., 8-Substituted O6-Cyclohexylmethylguanine Cdk2 Inhibitors; Using Structure-Based Inhibitor Design to Optimise an Alternative Binding Mode. J.Med.Chem. (2014)

Release Date

2013-12-18

Peptides

CYCLIN-DEPENDENT KINASE 2: A
CYCLIN-A2: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

CYCLIN-DEPENDENT KINASE 2

CYCLIN-A2

Related Entries With Identical Sequence